Combination vaccines containing DTPa-Hib: Impact of IPV and coadministration of CRM197 conjugates

Expert Review of Vaccines

Volumn 7, Issue 1, 2008, Pages 97-115

  Dagan, Ron ^b   Poolman, Jan T ^a   Zepp, Fred ^c  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Booster; Combination vaccine; Conjugate vaccine; Haemophilus influenzae type b; Hib; Immunity; Inactivated polio vaccine; Interference; Vaccine

Indexed keywords

ACELLULAR VACCINE; ANTIBODY; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID CRM197; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; HEPTAVALENT PNEUMOCOCCUS CONJUGATE VACCINE; IMMUNOGLOBULIN G ANTIBODY; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; PEDIACEL; PENTACEL; PENTAVAC; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE ANTIBODY; TRIHIBIT; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BLOOD GROUP TYPING; BYSTANDER EFFECT; CHILD CARE; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INHIBITION; DRUG TREATMENT FAILURE; ENVIRONMENTAL FACTOR; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; INFLUENZA; LICENSING; NEISSERIA MENINGITIDIS; PASSIVE IMMUNIZATION; POLIOMYELITIS; POPULATION RESEARCH; PRIORITY JOURNAL; REVACCINATION; REVIEW; UNITED KINGDOM;

BACTERIAL PROTEINS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; GREAT BRITAIN; HAEMOPHILUS VACCINES; HUMANS; POLIOVIRUS VACCINE, INACTIVATED;

EID: 40549101872     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.1.97     Document Type: Review

References (118)